Krystal Scharon

[Desmoid Tumor Research Foundation @DTRFoundation]

DTRF would like to thank the CTOS members who attended yesterday's @PeerView symposium on novel therapies for #desmoid tumor treatment at #CTOS2022!

PLEASE NOTE: A *virtual* rebroadcast of this symposium will be held on Nov. 29th @ 7pm EST. Register: https://t.co/VMIaIxOTxi

[Krystal Scharon @krystal_scharon]

At #CTOS2022 in Vancouver? Join @PeerView tonight @ 7:00pm PST @ Vancouver Convention Centre
East Meeting Rooms 1-3 for a dinner symposium on #desmoid tumors w/ experts Drs. Kasper, Gounder, & @alegronchi https://t.co/Pa8oW7n42G

[Desmoid Tumor Research Foundation @DTRFoundation]

TOMORROW, 11/17 @ 7pm PST during #CTOS2022, @PeerView will offer a CME satellite symposium on novel therapeutic approaches for #desmoid tumors based on recent clinical trial evidence with experts Drs. Kasper, Gounder, & @alegronchi.
REGISTER TODAY: https://t.co/VMIaIxPrmQ

[PeerView @PeerView]

Watch Peter H. Jones, MD, MNLA, and R. Scott Wright, MD, discuss the latest #hyperlipidemia updates from #AHA2022 - to participate, visit: https://t.co/5iDONJ2nvv https://t.co/8SYQiD96XN

[Krystal Scharon @krystal_scharon]

At #AHA22 in Chicago? Join @PeerView tomorrow, November 7 @ 6:00 AM CST (6:30 AM CST virtually) for a #Hyperlipidemia symposium @ the Hyatt Regency McCormick Place,
Regency Ballroom CDE, Level Two w/ experts @ScottWrightMD & Dr. Peter Jones! https://t.co/Fb3hgp7LF3 #MedTwitter

[Krystal Scharon @krystal_scharon]

Greetings from #AHA22 in Chicago! Join @PeerView for a #HeartFailure symposium tonight @ 5:30 PM CDT (6 PM CDT virtually) at the Marriott Marquis Chicago, Grand Horizon Ballroom E, Level Four w/ @JavedButler1, @AliceYYCheng, & @mvaduganathan https://t.co/f7lzu7RTuT #MedTwitter

[Jen Silverman @SpeakJen]

Join @PeerView at #AHA22 on 11/5 at 6:30 AM CDT (7:30 AM EDT virtually) at the Hyatt Regency McCormick Place, Prairie Room, Level Two w/ Dr. Moslehi (@CardioOncology) & Dr. Johnson. Do NOT miss this Cardio-Oncology Symposium! Register TODAY‼️ https://t.co/ItmkjeVfPn #MedTwitter

[Jen Silverman @SpeakJen]

Still time to register for the @PeerView #AHA22 #HeartFailure symposium on 11/5 at 6 PM CDT (7 PM EDT virtually) at the Marriott Marquis Chicago, Grand Horizon Ballroom E, Level Four w/ @JavedButler1, @AliceYYCheng, & @mvaduganathan‼️ https://t.co/d1qwyNB1S2 #MedTwitter

[PeerView @PeerView]

Watch Leonard B. Bacharier, MD, and Monica Kraft, MD, discuss the latest #SevereAsthma updates- to participate, visit: https://t.co/JQmfPZaPGb https://t.co/dxVce3fZni

[Jen Silverman @SpeakJen]

Do NOT miss @PeerView at #CHEST2022‼️ Register today for this unique 'How I Think, How I Treat' educational #SevereAsthma symposium on Monday, October 17th at 6:45 AM CDT (or 7:45 AM EDT virtually). Never too late to register! ➡️https://t.co/u39A7lC5Ql⬅️ #MedTwitter

[PeerView @PeerView]

Register today to meet expert faculty Praneetha Thulasi, MD, & Jonathan L. Kaufman, MD, for a live #MedEd #MultipleMyeloma event in Chicago (or watch them virtually!) on Friday, 9/30 at 7:00 PM CDT during #AAO2022! https://t.co/xLCTu7hlbd #Ophthalmology #Oncology #EyeHealth

[PeerView @PeerView]

Watch Guillermo Garcia-Manero, MD, and Gail J. Roboz, MD, discuss the latest #MyelodysplasticSyndrome updates - to participate, visit: https://t.co/ghat0EKS3O https://t.co/p6YjoFVRcd

[PeerView @PeerView]

Keeping current with the latest targeted tx advances in resectable #NSCLC? Join us 9/30 at 12:30 PM EDT for expert recommendations on optimizing perioperative #EGFR targeted therapy to improve outcomes https://t.co/k8DL7HTUMC #ThoracicSummit2022 #MedEd @BrendonStilesMD @AATSHQ

[PeerView @PeerView]

Learn to navigate the new evidence on perioperative #Immunotherapy, including neoadjuvant, adjuvant & combined approaches, with Drs. Altorki (@AltorkiNasser) & Spicer on 9/30 at 6:30 PM EDT during #ThoracicSummit2022 https://t.co/RVoIVXMSSM #LungCancer #NSCLC #AATS @AATSHQ

[PeerView @PeerView]

Watch Alexander Drilon, MD, George D. Demetri, MD, and Vivek Subbiah, MD discuss the latest #PrecisionMedicine for #SolidTumors updates - to participate, visit: https://t.co/y2RcJqbPmm https://t.co/IQZEMT6x9k

[PeerView @PeerView]

A new era of #PrecisionMedicine has arrived. Register for a 7/28 PeerView Live Virtual Workshop at 12 PM EDT to learn how new findings on gene fusions & other key alterations (NTRK, RET, & others) can change outcomes for your patients with #SolidTumors https://t.co/xVChjQnbpj

[PeerView @PeerView]

1/5 Thank you 🙌 for joining us for this #Tweetorial!

Why is the diagnosis of nontuberculous mycobacterial #LungDisease, or NTM-LD, often missed or delayed❓@MedTweetorials #NTMLD #MedEd #MedTwitter

[PeerView @PeerView]

At #EHA22? Join Prof. Dr. Stephan Stilgenbauer, Paolo Ghia, MD, PhD, & Nicole Lamanna, MD now in Lehar 3-4 to hear the New Rules for BTK Inhibitors in #CLL https://t.co/1pPJhvXWLp #MedEd

[𝗖𝗵𝗿𝗶𝘀 𝗞𝗿𝗶𝘇 𝗠𝗛𝗔 𝗖𝗛𝗖𝗣 @cQIme]

@PeerView

[PeerView @PeerView]

At #EHA22? Join expert Drs. Toby A. Eyre and Anthony R. Mato now in room Lehar 3-4 for a discussion on how data has improved the use of BTK inhibitors in B-Cell cancers!  https://t.co/UNp8TG800s #Lymphoma #lymsm #MedTwitter